BPC-157 hasn't been approved by the FDA. But that hasn't stopped this buzzy drug from gaining traction – and attention from MAHA.

The gray market is awash with BPC-157, a drug hyped as a cure-all, but unapproved by the FDA. Will RFK Jr. change that?

Docusign’s Allan Thygesen says ‘not providing an AI service isn't really an option.' ...

In an age where cyber attackers have become more intelligent, agile, persistent, sophisticated, and empowered by Artificial ...